当前位置: 首页 > 期刊 > 《中国现代医生》 > 2013年第2期
编号:12360998
中低位直肠癌术前超分割放疗联合FOLFIRI方案全身化疗的临床疗效观察(3)
http://www.100md.com 2013年1月15日 《中国现代医生》 2013年第2期
     [6] 张可领,肖作平,于恩达. 术前放疗和化疗在低位直肠癌保肛治疗中的作用[J]. 现代肿瘤医学,2006,14(2):205-207.

    [7] Engstrom PF,Arnoletti JP. NCCN Clinical Practice Guidelines in oncology rectal cancer[J]. J Natl Compr Canc Netw,2009,7(8):838-881.

    [8] Fu KK,Pajak TF,Trotti A,et al. A Radiation Therapy Oncology Group(RTOG) phaseⅢrandomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas:first report of RTOG 9003[J]. Int J Radiat Oncol Biol Phys,2000,48(1):7-16.

    [9] V Voelter. CPT-11 and concomitant hyperfractionated accelerated radiotherapy induce efficient local control in rectal cancer patients:results from a phaseⅡ[J]. British Journal of Cancer,2006,95:710-716.

    [10] 邱荣良. 术前加速超分割放射治疗直肠癌临床研究[J]. 中国肿瘤临床与康复,2005,12(3):215-217.

    [11] Marsh Rde W,George TJ,Siddiqui T,et al. A phase II trial of neoadjuvant capecitabine combined with hyperfractionated accelerated radiation therapy in locally advanced rectal cancer[J]. American Journal of Clinical Oncology,2010,33(3):251-256.

    (收稿日期:2012-11-20)

    , http://www.100md.com(王忠瑜 范立 陈明晓 邢月明)
上一页1 2 3